AddLife acquired BonsaiLab in mid-2024
BonsaiLab specializes in niche Medtech and Labtech areas, partnering with Josep Carreras Leukaemia Research Institute to advance genomics against leukaemia.
See the latest news and media coverage for AddLife. We track all announcements, press releases, and industry mentions in real time, all in one place.
European life science partner
add.lifeLast updated
In short: AddLife achieved strong profitability in 2025 and 2026 while accelerating its acquisition strategy through its decentralized business model.
BonsaiLab specializes in niche Medtech and Labtech areas, partnering with Josep Carreras Leukaemia Research Institute to advance genomics against leukaemia.
Resolutions passed include adoption of financial statements, SEK 1.50 dividend per share, board re-elections, new director Fredrik Rågmark, LTIP 2026, and share repurchase authorizations.
Report shows high margins, increased acquisitions, and positive trends. Video conference airs at 09.00 CET.
Net sales fell 2% to SEK 2,645m; EBITA margin 12.5%; profit after tax up 7%. Acquired BioSpectrum and CoaChrom.
Resolutions, including the following, were passed by the Annual General Meeting ("AGM") and the ensuing statutory Board of Directors Meeting of AddLife AB (the "Company...
This article first appeared on GuruFocus. Release Date: April 28, 2026 For the complete transcript of the earnings call, please refer to the full earnings...
Swedish life science supplier AddLife on Tuesday reported first-quarter net sales of SEK 2.65 billion, missing the average analyst estimate of SEK 2.74 billion. The...
The medtech company Addlife reports a net profit of 128 million kronor for the first quarter of 2026 (120). Earnings per share amounted to...
Track AddLife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to AddLife and other trending companies.